2018-2023 Global Microbiome Therapeutics Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Microbiome Therapeutics market for 2018-2023.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
Over the next five years, LPI(LP Information) projects that Microbiome Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Microbiome Therapeutics market for 2018-2023.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
Over the next five years, LPI(LP Information) projects that Microbiome Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Type I
- Type II
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
Research objectives
- To study and analyze the global Microbiome Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Microbiome Therapeutics market by identifying its various subsegments.
- Focuses on the key global Microbiome Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Microbiome Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Microbiome Therapeutics submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Consumption 2013-2023
2.1.2 Microbiome Therapeutics Consumption CAGR by Region
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Microbiome Therapeutics Consumption by Type
2.3.1 Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Microbiome Therapeutics Sale Price by Type (2013-2018)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 Inflammatory Bowel Disease (IBD)
2.4.2 Orphan Drug
2.4.3 Immuno-oncology
2.4.4 Others
2.5 Microbiome Therapeutics Consumption by Application
2.5.1 Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Microbiome Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Microbiome Therapeutics Sale Price by Application (2013-2018)
3 GLOBAL MICROBIOME THERAPEUTICS BY PLAYERS
3.1 Global Microbiome Therapeutics Sales Market Share by Players
3.1.1 Global Microbiome Therapeutics Sales by Players (2016-2018)
3.1.2 Global Microbiome Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Microbiome Therapeutics Revenue Market Share by Players
3.2.1 Global Microbiome Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Microbiome Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Microbiome Therapeutics Sale Price by Players
3.4 Global Microbiome Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Microbiome Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Microbiome Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS BY REGIONS
4.1 Microbiome Therapeutics by Regions
4.1.1 Global Microbiome Therapeutics Consumption by Regions
4.1.2 Global Microbiome Therapeutics Value by Regions
4.2 Americas Microbiome Therapeutics Consumption Growth
4.3 APAC Microbiome Therapeutics Consumption Growth
4.4 Europe Microbiome Therapeutics Consumption Growth
4.5 Middle East & Africa Microbiome Therapeutics Consumption Growth
5 AMERICAS
5.1 Americas Microbiome Therapeutics Consumption by Countries
5.1.1 Americas Microbiome Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Microbiome Therapeutics Value by Countries (2013-2018)
5.2 Americas Microbiome Therapeutics Consumption by Type
5.3 Americas Microbiome Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Microbiome Therapeutics Consumption by Countries
6.1.1 APAC Microbiome Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Microbiome Therapeutics Value by Countries (2013-2018)
6.2 APAC Microbiome Therapeutics Consumption by Type
6.3 APAC Microbiome Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Microbiome Therapeutics by Countries
7.1.1 Europe Microbiome Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Microbiome Therapeutics Value by Countries (2013-2018)
7.2 Europe Microbiome Therapeutics Consumption by Type
7.3 Europe Microbiome Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome Therapeutics by Countries
8.1.1 Middle East & Africa Microbiome Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Microbiome Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Microbiome Therapeutics Consumption by Type
8.3 Middle East & Africa Microbiome Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Microbiome Therapeutics Distributors
10.3 Microbiome Therapeutics Customer
11 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST
11.1 Global Microbiome Therapeutics Consumption Forecast (2018-2023)
11.2 Global Microbiome Therapeutics Forecast by Regions
11.2.1 Global Microbiome Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Microbiome Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Microbiome Therapeutics Forecast by Type
11.8 Global Microbiome Therapeutics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Seres Therapeutics
12.1.1 Company Details
12.1.2 Microbiome Therapeutics Product Offered
12.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Seres Therapeutics News
12.2 Assembly Biosciences
12.2.1 Company Details
12.2.2 Microbiome Therapeutics Product Offered
12.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Assembly Biosciences News
12.3 Synthetic Biologics
12.3.1 Company Details
12.3.2 Microbiome Therapeutics Product Offered
12.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Synthetic Biologics News
12.4 Interxon
12.4.1 Company Details
12.4.2 Microbiome Therapeutics Product Offered
12.4.3 Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Interxon News
12.5 PureTech
12.5.1 Company Details
12.5.2 Microbiome Therapeutics Product Offered
12.5.3 PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 PureTech News
12.6 Synlogic
12.6.1 Company Details
12.6.2 Microbiome Therapeutics Product Offered
12.6.3 Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Synlogic News
12.7 Enterome BioScience
12.7.1 Company Details
12.7.2 Microbiome Therapeutics Product Offered
12.7.3 Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Enterome BioScience News
12.8 4D Pharma
12.8.1 Company Details
12.8.2 Microbiome Therapeutics Product Offered
12.8.3 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 4D Pharma News
12.9 Second Genome
12.9.1 Company Details
12.9.2 Microbiome Therapeutics Product Offered
12.9.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Second Genome News
12.10 AOBiome
12.10.1 Company Details
12.10.2 Microbiome Therapeutics Product Offered
12.10.3 AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 AOBiome News
12.11 C3 Jian
12.12 Rebiotix
12.13 MicroBiome Therapeutics LLC
12.14 Metabiomics
12.15 Ritter Pharmaceuticals
12.16 Symberix
12.17 OpenBiome
12.18 Azitra
12.19 Symbiotix Biotherapies
12.20 Osel
12.21 Metabogen
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Consumption 2013-2023
2.1.2 Microbiome Therapeutics Consumption CAGR by Region
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Microbiome Therapeutics Consumption by Type
2.3.1 Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Microbiome Therapeutics Sale Price by Type (2013-2018)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 Inflammatory Bowel Disease (IBD)
2.4.2 Orphan Drug
2.4.3 Immuno-oncology
2.4.4 Others
2.5 Microbiome Therapeutics Consumption by Application
2.5.1 Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Microbiome Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Microbiome Therapeutics Sale Price by Application (2013-2018)
3 GLOBAL MICROBIOME THERAPEUTICS BY PLAYERS
3.1 Global Microbiome Therapeutics Sales Market Share by Players
3.1.1 Global Microbiome Therapeutics Sales by Players (2016-2018)
3.1.2 Global Microbiome Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Microbiome Therapeutics Revenue Market Share by Players
3.2.1 Global Microbiome Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Microbiome Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Microbiome Therapeutics Sale Price by Players
3.4 Global Microbiome Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Microbiome Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Microbiome Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS BY REGIONS
4.1 Microbiome Therapeutics by Regions
4.1.1 Global Microbiome Therapeutics Consumption by Regions
4.1.2 Global Microbiome Therapeutics Value by Regions
4.2 Americas Microbiome Therapeutics Consumption Growth
4.3 APAC Microbiome Therapeutics Consumption Growth
4.4 Europe Microbiome Therapeutics Consumption Growth
4.5 Middle East & Africa Microbiome Therapeutics Consumption Growth
5 AMERICAS
5.1 Americas Microbiome Therapeutics Consumption by Countries
5.1.1 Americas Microbiome Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Microbiome Therapeutics Value by Countries (2013-2018)
5.2 Americas Microbiome Therapeutics Consumption by Type
5.3 Americas Microbiome Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Microbiome Therapeutics Consumption by Countries
6.1.1 APAC Microbiome Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Microbiome Therapeutics Value by Countries (2013-2018)
6.2 APAC Microbiome Therapeutics Consumption by Type
6.3 APAC Microbiome Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Microbiome Therapeutics by Countries
7.1.1 Europe Microbiome Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Microbiome Therapeutics Value by Countries (2013-2018)
7.2 Europe Microbiome Therapeutics Consumption by Type
7.3 Europe Microbiome Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome Therapeutics by Countries
8.1.1 Middle East & Africa Microbiome Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Microbiome Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Microbiome Therapeutics Consumption by Type
8.3 Middle East & Africa Microbiome Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Microbiome Therapeutics Distributors
10.3 Microbiome Therapeutics Customer
11 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST
11.1 Global Microbiome Therapeutics Consumption Forecast (2018-2023)
11.2 Global Microbiome Therapeutics Forecast by Regions
11.2.1 Global Microbiome Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Microbiome Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Microbiome Therapeutics Forecast by Type
11.8 Global Microbiome Therapeutics Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Seres Therapeutics
12.1.1 Company Details
12.1.2 Microbiome Therapeutics Product Offered
12.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Seres Therapeutics News
12.2 Assembly Biosciences
12.2.1 Company Details
12.2.2 Microbiome Therapeutics Product Offered
12.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Assembly Biosciences News
12.3 Synthetic Biologics
12.3.1 Company Details
12.3.2 Microbiome Therapeutics Product Offered
12.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Synthetic Biologics News
12.4 Interxon
12.4.1 Company Details
12.4.2 Microbiome Therapeutics Product Offered
12.4.3 Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Interxon News
12.5 PureTech
12.5.1 Company Details
12.5.2 Microbiome Therapeutics Product Offered
12.5.3 PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 PureTech News
12.6 Synlogic
12.6.1 Company Details
12.6.2 Microbiome Therapeutics Product Offered
12.6.3 Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Synlogic News
12.7 Enterome BioScience
12.7.1 Company Details
12.7.2 Microbiome Therapeutics Product Offered
12.7.3 Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Enterome BioScience News
12.8 4D Pharma
12.8.1 Company Details
12.8.2 Microbiome Therapeutics Product Offered
12.8.3 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 4D Pharma News
12.9 Second Genome
12.9.1 Company Details
12.9.2 Microbiome Therapeutics Product Offered
12.9.3 Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Second Genome News
12.10 AOBiome
12.10.1 Company Details
12.10.2 Microbiome Therapeutics Product Offered
12.10.3 AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 AOBiome News
12.11 C3 Jian
12.12 Rebiotix
12.13 MicroBiome Therapeutics LLC
12.14 Metabiomics
12.15 Ritter Pharmaceuticals
12.16 Symberix
12.17 OpenBiome
12.18 Azitra
12.19 Symbiotix Biotherapies
12.20 Osel
12.21 Metabogen
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Microbiome Therapeutics
Table Product Specifications of Microbiome Therapeutics
Figure Microbiome Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Microbiome Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Microbiome Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Microbiome Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type II
Table Major Players of Type II
Table Global Consumption Sales by Type (2013-2018)
Table Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Microbiome Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Microbiome Therapeutics Value Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Sale Price by Type (2013-2018)
Figure Microbiome Therapeutics Consumed in Inflammatory Bowel Disease (IBD)
Figure Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2013-2018) ($ Millions)
Figure Global Inflammatory Bowel Disease (IBD) YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Orphan Drug
Figure Global Microbiome Therapeutics Market: Orphan Drug (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Orphan Drug (2013-2018) ($ Millions)
Figure Global Orphan Drug YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Immuno-oncology
Figure Global Microbiome Therapeutics Market: Immuno-oncology (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Immuno-oncology (2013-2018) ($ Millions)
Figure Global Immuno-oncology YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Others
Figure Global Microbiome Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Microbiome Therapeutics Value by Application (2013-2018)
Table Global Microbiome Therapeutics Value Market Share by Application (2013-2018)
Figure Global Microbiome Therapeutics Value Market Share by Application (2013-2018)
Table Global Microbiome Therapeutics Sale Price by Application (2013-2018)
Table Global Microbiome Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Microbiome Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Microbiome Therapeutics Sales Market Share by Players in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Players in 2017
Table Global Microbiome Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Microbiome Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Players in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Players in 2017
Table Global Microbiome Therapeutics Sale Price by Players (2016-2018)
Figure Global Microbiome Therapeutics Sale Price by Players in 2017
Table Global Microbiome Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Microbiome Therapeutics Products Offered
Table Microbiome Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Microbiome Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Microbiome Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Microbiome Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Microbiome Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Microbiome Therapeutics Value Market Share by Regions 2013-2018
Figure Global Microbiome Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Microbiome Therapeutics Value 2013-2018 ($ Millions)
Table Americas Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Americas Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Microbiome Therapeutics Value Market Share by Countries in 2017
Table Americas Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Americas Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure United States Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table APAC Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Microbiome Therapeutics Value Market Share by Countries in 2017
Table APAC Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Type in 2017
Table APAC Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure China Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Europe Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Value Market Share by Countries in 2017
Table Europe Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Europe Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure Germany Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Microbiome Therapeutics Distributors List
Table Microbiome Therapeutics Customer List
Figure Global Microbiome Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Microbiome Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Forecast by Regions
Table Global Microbiome Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Regions
Figure Americas Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure United States Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure United States Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure China Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure China Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure India Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure India Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure France Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure France Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure UK Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure UK Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Microbiome Therapeutics Value 2018-2023 ($ Millions)
Table Global Microbiome Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Microbiome Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Seres Therapeutics Microbiome Therapeutics Market Share (2016-2018)
Table Assembly Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Assembly Biosciences Microbiome Therapeutics Market Share (2016-2018)
Table Synthetic Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synthetic Biologics Microbiome Therapeutics Market Share (2016-2018)
Table Interxon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Interxon Microbiome Therapeutics Market Share (2016-2018)
Table PureTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure PureTech Microbiome Therapeutics Market Share (2016-2018)
Table Synlogic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synlogic Microbiome Therapeutics Market Share (2016-2018)
Table Enterome BioScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Enterome BioScience Microbiome Therapeutics Market Share (2016-2018)
Table 4D Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure 4D Pharma Microbiome Therapeutics Market Share (2016-2018)
Table Second Genome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Second Genome Microbiome Therapeutics Market Share (2016-2018)
Table AOBiome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AOBiome Microbiome Therapeutics Market Share (2016-2018)
Table C3 Jian Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rebiotix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabiomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Symberix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OpenBiome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Azitra Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Symbiotix Biotherapies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Osel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure Picture of Microbiome Therapeutics
Table Product Specifications of Microbiome Therapeutics
Figure Microbiome Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Microbiome Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Microbiome Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Microbiome Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Type I
Table Major Players of Type I
Figure Product Picture of Type II
Table Major Players of Type II
Table Global Consumption Sales by Type (2013-2018)
Table Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Microbiome Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Microbiome Therapeutics Value Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Sale Price by Type (2013-2018)
Figure Microbiome Therapeutics Consumed in Inflammatory Bowel Disease (IBD)
Figure Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Inflammatory Bowel Disease (IBD) (2013-2018) ($ Millions)
Figure Global Inflammatory Bowel Disease (IBD) YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Orphan Drug
Figure Global Microbiome Therapeutics Market: Orphan Drug (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Orphan Drug (2013-2018) ($ Millions)
Figure Global Orphan Drug YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Immuno-oncology
Figure Global Microbiome Therapeutics Market: Immuno-oncology (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Immuno-oncology (2013-2018) ($ Millions)
Figure Global Immuno-oncology YoY Growth ($ Millions)
Figure Microbiome Therapeutics Consumed in Others
Figure Global Microbiome Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Microbiome Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Microbiome Therapeutics Value by Application (2013-2018)
Table Global Microbiome Therapeutics Value Market Share by Application (2013-2018)
Figure Global Microbiome Therapeutics Value Market Share by Application (2013-2018)
Table Global Microbiome Therapeutics Sale Price by Application (2013-2018)
Table Global Microbiome Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Microbiome Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Microbiome Therapeutics Sales Market Share by Players in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Players in 2017
Table Global Microbiome Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Microbiome Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Players in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Players in 2017
Table Global Microbiome Therapeutics Sale Price by Players (2016-2018)
Figure Global Microbiome Therapeutics Sale Price by Players in 2017
Table Global Microbiome Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Microbiome Therapeutics Products Offered
Table Microbiome Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Microbiome Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Microbiome Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Microbiome Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Microbiome Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Microbiome Therapeutics Value Market Share by Regions 2013-2018
Figure Global Microbiome Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Microbiome Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Microbiome Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Microbiome Therapeutics Value 2013-2018 ($ Millions)
Table Americas Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Americas Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Microbiome Therapeutics Value Market Share by Countries in 2017
Table Americas Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Americas Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure United States Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table APAC Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Microbiome Therapeutics Value Market Share by Countries in 2017
Table APAC Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Type in 2017
Table APAC Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure China Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Europe Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Microbiome Therapeutics Value Market Share by Countries in 2017
Table Europe Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Europe Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure Germany Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Microbiome Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Microbiome Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Microbiome Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Microbiome Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Microbiome Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Microbiome Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Microbiome Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Microbiome Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Microbiome Therapeutics Value Growth 2013-2018 ($ Millions)
Table Microbiome Therapeutics Distributors List
Table Microbiome Therapeutics Customer List
Figure Global Microbiome Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Microbiome Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Forecast by Regions
Table Global Microbiome Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Regions
Figure Americas Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure United States Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure United States Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure China Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure China Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure India Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure India Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure France Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure France Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure UK Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure UK Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Microbiome Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Microbiome Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Microbiome Therapeutics Value 2018-2023 ($ Millions)
Table Global Microbiome Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Microbiome Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Microbiome Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Microbiome Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seres Therapeutics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Seres Therapeutics Microbiome Therapeutics Market Share (2016-2018)
Table Assembly Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Assembly Biosciences Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Assembly Biosciences Microbiome Therapeutics Market Share (2016-2018)
Table Synthetic Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synthetic Biologics Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synthetic Biologics Microbiome Therapeutics Market Share (2016-2018)
Table Interxon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Interxon Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Interxon Microbiome Therapeutics Market Share (2016-2018)
Table PureTech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table PureTech Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure PureTech Microbiome Therapeutics Market Share (2016-2018)
Table Synlogic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synlogic Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synlogic Microbiome Therapeutics Market Share (2016-2018)
Table Enterome BioScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Enterome BioScience Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Enterome BioScience Microbiome Therapeutics Market Share (2016-2018)
Table 4D Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 4D Pharma Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure 4D Pharma Microbiome Therapeutics Market Share (2016-2018)
Table Second Genome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Second Genome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Second Genome Microbiome Therapeutics Market Share (2016-2018)
Table AOBiome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AOBiome Microbiome Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AOBiome Microbiome Therapeutics Market Share (2016-2018)
Table C3 Jian Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rebiotix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabiomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Symberix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table OpenBiome Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Azitra Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Symbiotix Biotherapies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Osel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Metabogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
